Cationic Antimicrobial Peptides and Biogenic Silver Nanoparticles Kill Mycobacteria without Eliciting DNA Damage and Cytotoxicity in Mouse Macrophages
Open Access
- 1 August 2013
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 57 (8), 3688-3698
- https://doi.org/10.1128/aac.02475-12
Abstract
With the emergence of multidrug-resistant mycobacterial strains, better therapeutic strategies are required for the successful treatment of the infection. Although antimicrobial peptides (AMPs) and silver nanoparticles (AgNPs) are becoming one of the popular antibacterial agents, their antimycobacterial potential is not fully evaluated. In this study, we synthesized biogenic-silver nanoparticles using bacterial, fungal, and plant biomasses and analyzed their antibacterial activities in combination with AMPs against mycobacteria. Mycobacterium smegmatis was found to be more susceptible to AgNPs compared to M. marinum . We found that NK-2 showed enhanced killing effect with NP-1 and NP-2 biogenic nanoparticles at a 0.5-ppm concentration, whereas LLKKK-18 showed antibacterial activity only with NP-2 at 0.5-ppm dose against M. smegmatis . In case of M. marinum NK-2 did not show any additive activity with NP-1 and NP-2 and LLKKK-18 alone completely inhibited the bacterial growth. Both NP-1 and NP-2 also showed increased killing of M. smegmatis in combination with the antituberculosis drug rifampin. The sizes and shapes of the AgNPs were determined by transmission electron microscopy and dynamic light scattering. AgNPs showed no cytotoxic or DNA damage effects on macrophages at the mycobactericidal dose, whereas treatment with higher doses of AgNPs caused toxicity and micronuclei formation in cytokinesis blocked cells. Macrophages actively endocytosed fluorescein isothiocyanate-labeled AgNPs resulting in nitric oxide independent intracellular killing of M. smegmatis . Apoptosis and cell cycle studies showed that treatment with higher dose of AgNPs arrested macrophages at the G 1 -phase. In summary, our data suggest the combined effect of biogenic-AgNPs and antimicrobial peptides as a promising antimycobacterial template.This publication has 54 references indexed in Scilit:
- Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cellsInternational Journal of Nanomedicine, 2012
- Structural Differences in Lipomannans from Pathogenic and Nonpathogenic Mycobacteria That Impact CD1b-restricted T Cell Responses*Online Journal of Public Health Informatics, 2011
- Macrophage endocytic trafficking of antiretroviral nanoparticlesNanomedicine, 2011
- Membrane-active antimicrobial peptides and human placental lysosomal extracts are highly active against mycobacteriaPeptides, 2011
- Controlled Release of Biologically Active Silver from Nanosilver SurfacesACS Nano, 2010
- Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549Archives of Toxicology, 2010
- Role of the Mycobacterium tuberculosis P55 Efflux Pump in Intrinsic Drug Resistance, Oxidative Stress Responses, and GrowthAntimicrobial Agents and Chemotherapy, 2009
- Unique Cellular Interaction of Silver Nanoparticles: Size-Dependent Generation of Reactive Oxygen SpeciesThe Journal of Physical Chemistry B, 2008
- The effect of particle design on cellular internalization pathwaysProceedings of the National Academy of Sciences of the United States of America, 2008
- The Antimicrobial Peptide NK-2, the Core Region of Mammalian NK-Lysin, Kills Intraerythrocytic Plasmodium falciparumAntimicrobial Agents and Chemotherapy, 2008